Finance

Beta
Lists
014570:KOSDAQ
Korean Drug Co Ltd
â‚©3,350.00
+3.08%
(+100.00) 1D
Jun 11, 3:30:23 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 014570...
Open
â‚©3,250
High
â‚©3,375
Low
â‚©3,210
Mkt. cap
36.85B
Avg. vol.
23.15K
Volume
10.83K
Dividend
5.37%
Quarterly dividend
â‚©45
Ex-dividend date
Dec 29, 2021
P/E ratio
5.27
52-wk high
â‚©5,170
52-wk low
â‚©3,060
EPS
â‚©636
Shares outstanding
11.00M
No. of employees
233
Open
â‚©3,250
High
â‚©3,375
Low
â‚©3,210
Mkt. cap
36.85B
Avg. vol.
23.15K
Volume
10.83K
Dividend
5.37%
Quarterly dividend
â‚©45
Ex-dividend date
Dec 29, 2021
P/E ratio
5.27
52-wk high
â‚©5,170
52-wk low
â‚©3,060
EPS
â‚©636
Shares outstanding
11.00M
No. of employees
233
News stories
From sources across the web
About Korean Drug Co Ltd
CEO-
Employees233
Founded1980
Headquarters-
SectorPharmaceutical industry
Website-
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
14.94B
16.49B
18.00B
13.34B
Cost of goods sold
8.07B
9.56B
10.52B
7.18B
Cost of revenue
8.07B
9.56B
10.52B
7.18B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.47B
4.71B
5.36B
4.72B
Operating expense
4.63B
4.95B
5.59B
4.98B
Total operating expenses
12.70B
14.51B
16.11B
12.16B
Operating income
2.24B
1.98B
1.89B
1.18B
Other non operating income
32.49M
217.29M
141.47M
35.62M
EBT including unusual items
2.42B
2.31B
2.14B
1.46B
EBT excluding unusual items
2.41B
2.37B
2.20B
1.43B
Income tax expense
433.51M
405.85M
330.65M
259.40M
Effective tax rate
17.89%
17.54%
15.43%
17.76%
Other operating expenses
86.58M
152.56M
147.51M
115.08M
Net income
1.99B
1.91B
1.81B
1.20B
Net profit margin
13.32%
11.58%
10.07%
9.01%
Earnings per share
-
-
-
-
Interest and investment income
158.62M
161.56M
178.88M
200.37M
Interest expense
-807.00K
-1.09M
-923.00K
-1.13M
Net interest expenses
157.81M
160.47M
177.96M
199.24M
Depreciation and amortization charges
69.80M
80.10M
78.84M
79.46M
EBITDA
2.72B
2.48B
2.38B
1.66B
Gain or loss from assets sale
4.80M
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer